Dumping Syndrome Recruiting Phase 4 Trials for Pasireotide (DB06663)

Also known as: Syndromes, Dumping

IndicationStatusPhase
DBCOND0000855 (Dumping Syndrome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01794793Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesTreatment